Leap Therapeutics, Inc. (LPTX) Financials
LPTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 72.8 million | 12.7 million |
2023-09-30 | 83.0 million | 11.0 million |
2023-06-30 | 95.9 million | 11.8 million |
2023-03-31 | 106.5 million | 78.2 million |
LPTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -10.4 million | 1.3 million |
2023-09-30 | -10.5 million | 1.3 million |
2023-06-30 | -10.2 million | 1.3 million |
2023-03-31 | -12.7 million | 1.3 million |
LPTX Net Income
No data available :(
LPTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 70.6 million | - | 262000 |
2023-09-30 | 80.7 million | - | 369000 |
2023-06-30 | 91.4 million | - | 474000 |
2023-03-31 | 102.0 million | - | 577000 |
LPTX Shares Outstanding
LPTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 11.7 million | 3.1 million | 110000 |
2023-09-30 | - | 11.5 million | 3.3 million | - |
2023-06-30 | 348000 | 11.1 million | 3.6 million | - |
2023-03-31 | 348000 | 38.9 million | 3.8 million | - |
LPTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 634000 | 110000 |
2023-09-30 | - | 107000 |
2023-06-30 | - | 106000 |
2023-03-31 | - | 104000 |
LPTX
Price: $3.19
52 week price:
Earnings Per Share: -3.98 USD
P/E Ratio: -0.73
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 72793
Ebitda: -6.8 millionMarket Capitalization: 65.0 million